Rea CJ - Search Results

1

A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders.

Gandhi PS, Zivkovic M, Østergaard H, Bonde AC, Elm T, Løvgreen MN, Schluckebier G, Johansson E, Olsen OH, Olsen EHN, de Bus IA, Bloem K, Alskär O, Rea CJ, Bjørn SE, Schutgens RE, Sørensen B, Urbanus RT, Faber JH. Gandhi PS, et al. Among authors: rea cj. Nat Cardiovasc Res. 2024 Feb;3(2):166-185. doi: 10.1038/s44161-023-00418-4. Epub 2024 Feb 8. Nat Cardiovasc Res. 2024. PMID: 39196196 Free PMC article.

2

The role of fibrinogen: a new paradigm in the treatment of coagulopathic bleeding.

Sørensen B, Tang M, Larsen OH, Laursen PN, Fenger-Eriksen C, Rea CJ. Sørensen B, et al. Among authors: rea cj. Thromb Res. 2011;128 Suppl 1:S13-6. doi: 10.1016/S0049-3848(12)70004-X. Thromb Res. 2011. PMID: 22221845 Review.

3

An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A.

Rea CJ, Foley JH, Bevan DH, Sørensen B. Rea CJ, et al. Ann Hematol. 2014 Apr;93(4):683-92. doi: 10.1007/s00277-013-1921-z. Epub 2013 Nov 6. Ann Hematol. 2014. PMID: 24193375

4

Pharmacokinetics, coagulation factor consumption and clinical efficacy in patients being switched from full-length FVIII treatment to B-domain-deleted r-FVIII and back to full-length FVIII.

Rea C, Dunkerley A, Sørensen B, Rangarajan S. Rea C, et al. Haemophilia. 2009 Nov;15(6):1237-42. doi: 10.1111/j.1365-2516.2009.02071.x. Epub 2009 Aug 2. Haemophilia. 2009. PMID: 19664015

5

Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A.

Rea CJ, Foley JH, Ingerslev J, Sørensen B. Rea CJ, et al. J Thromb Haemost. 2011 Mar;9(3):510-6. doi: 10.1111/j.1538-7836.2010.04171.x. J Thromb Haemost. 2011. PMID: 21155966 Free article. Clinical Trial.

6

Factor XIII in the treatment of hemophilia A.

Rea CJ, Foley JH, Sørensen B. Rea CJ, et al. N Engl J Med. 2012 Jan 19;366(3):281-3. doi: 10.1056/NEJMc1113270. N Engl J Med. 2012. PMID: 22256823 No abstract available.

7

Temporal changes in clot lysis and clot stability following tranexamic acid in cardiac surgery.

Tang M, Wierup P, Rea CJ, Ingerslev J, Hjortdal VE, Sørensen B. Tang M, et al. Among authors: rea cj. Blood Coagul Fibrinolysis. 2017 Jun;28(4):295-302. doi: 10.1097/MBC.0000000000000595. Blood Coagul Fibrinolysis. 2017. PMID: 27607599

8

Fibrinogen as a hemostatic agent.

Sørensen B, Larsen OH, Rea CJ, Tang M, Foley JH, Fenger-Eriksen C. Sørensen B, et al. Among authors: rea cj. Semin Thromb Hemost. 2012 Apr;38(3):268-73. doi: 10.1055/s-0032-1309287. Epub 2012 Mar 29. Semin Thromb Hemost. 2012. PMID: 22460909 Review.

9

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

Foley JH, Petersen KU, Rea CJ, Harpell L, Powell S, Lillicrap D, Nesheim ME, Sørensen B. Foley JH, et al. Among authors: rea cj. Blood. 2012 Apr 12;119(15):3622-8. doi: 10.1182/blood-2011-11-392308. Epub 2012 Jan 10. Blood. 2012. PMID: 22234684 Free PMC article. Clinical Trial.

10

Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors.

Tran HT, Sørensen B, Rea CJ, Bjørnsen S, Ueland T, Pripp AH, Tjønnfjord GE, Holme PA. Tran HT, et al. Among authors: rea cj. Haemophilia. 2014 May;20(3):369-75. doi: 10.1111/hae.12318. Epub 2013 Nov 19. Haemophilia. 2014. PMID: 24251535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters